CN Patent

CN106749466B — 一种高纯度奥贝胆酸的制备方法

Assigned to FUDAN ZHANGJIANG BIOLOGICAL MEDICINE Co Ltd SHANGHAI · Expires 2019-05-21 · 7y expired

What this patent protects

本发明涉及一种高纯度奥贝胆酸的制备方法。以式II所示化合物鹅去氧胆酸(CDCA)为起始原料，经过氧化、酯化、羟基保护、亚乙基化、催化氢化、羰基还原以及酯水解反应得到高纯度的奥贝胆酸。本发明提供的奥贝胆酸制备方法具有低毒性、低污染、纯度高、立体选择性好、杂质含量少、反应条件温和、安全性高、生产操作简便等优点，适合工业化生产。

USPTO Abstract

本发明涉及一种高纯度奥贝胆酸的制备方法。以式II所示化合物鹅去氧胆酸(CDCA)为起始原料，经过氧化、酯化、羟基保护、亚乙基化、催化氢化、羰基还原以及酯水解反应得到高纯度的奥贝胆酸。本发明提供的奥贝胆酸制备方法具有低毒性、低污染、纯度高、立体选择性好、杂质含量少、反应条件温和、安全性高、生产操作简便等优点，适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN106749466B
Jurisdiction
CN
Classification
—
Expires
2019-05-21
Drug substance claim
No
Drug product claim
No
Assignee
FUDAN ZHANGJIANG BIOLOGICAL MEDICINE Co Ltd SHANGHAI
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.